Hanger Inc
Change company Symbol lookup
Select an option...
HNGR Hanger Inc
$RFTREES Refinitiv Eurozone ESG Select Index
NEMCF New Energy Metals Corp
SLCT Select Bancorp Inc
HPQ HP Inc
GOLD Barrick Gold Corp
DGNR Dragoneer Growth Opportunities Corp
EQMEF Equity Metals Corp
TS Tenaris SA
TRXC Transenterix Inc
Go

Health Care : Health Care Providers & Services | Small Cap Blend
Company profile

Hanger, Inc. is a rehabilitative product and service company. The Company delivers orthotic and prosthetic (O&P) patient care, products, services and therapeutic solutions. The Company offers advanced prosthetics and orthotics, clinically differentiated programs and unsurpassed customer service. The Company comprises nine business units that serve various segments of the O&P industry. The Company's segments include Patient Care, and Products & Services. The Patient Care segment includes Hanger Clinic and Linkia. The Hanger Clinic specializes in orthotic and prosthetic services and products. Linkia is a specialty healthcare company, which is engaged in the O&P management and care. The Products & Services segment includes Southern Prosthetic Supply (SPS), Accelerated Care Plus (ACP), SureFit, Innovative Neurotronics, Inc. and SPS National Labs.

Price
Delayed
$22.75
Day's Change
-0.37 (-1.60%)
Bid
--
Ask
--
B/A Size
--
Day's High
23.20
Day's Low
22.69
Volume
(Light)

Today's volume of 24,114 shares is on pace to be much lighter than HNGR's 10-day average volume of 126,424 shares.

24,114

UPDATE: CalPERS more than doubles Gilead and Zoom Video stakes, trims Apple and Microsoft

6:46 am ET August 13, 2020 (MarketWatch)
Print

California Public Employees Retirement System (CalPERS) disclosed Wednesday that it more than doubled its shares stakes in Gilead Sciences Inc. (GILD) and Zoom Video Communications Inc. , both of which have been beneficiaries of the COVID-19 pandemic, while it rebalanced its holdings of technology-behemoths Apple Inc. (AAPL) and Microsoft Corp. (MSFT) by trimming its stakes during the second quarter. As of June 30, the pension fund owned 10,528,157 million shares of Gilead, which makes COVID-19 treatment candidate remdesivir, up from 4,353,093 shares as of March 31, while its Zoom Video stake increased to 341,358 shares from 61,070 shares. Among other companies with COVID-19 vaccine candidates, the stake in Moderna Inc. (MRNA) increased to 599,997 shares from 449,100 shares and the Inovio Pharmaceuticals Inc. (INO) holding nearly doubled to 322,441 shares from 176,365 shares. CalPERS trimmed its stakes in Apple to 9,171,757 shares from 10,190,498 shares and in Microsoft to 16,850,303 shares from 17,404,566 shares. Meanwhile, given the rallies in the stocks, the market value of CalPERS holding in Apple increased to $3.35 billion as of June 30 from $2.59 billion as of March 31, while the value of the Microsoft shares it held rose to $3.43 billion from $2.74 billion. The overall market value of CalPERS's equity holdings increased 22.7% to $101.41 billion, while the S&P 500 gained 20.0% in the second quarter.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 13, 2020 06:46 ET (10:46 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.